Strategy & Events

Highlight of Tunisian Cardiology in 2025

The 12th Congress of the Association of Cardiologists, CV Surgeons, and Angiologists of Sfax was a landmark event! Philadelphia Pharma had the honor of organizing, in partnership with the Association, a symposium filled with innovations and interactive discussions on a topic central to personalized medicine:“Rivaroxaban: Specific Indications and Target Populations.”

Key Activities and Highlights:

  • Organization of the 12th Congress of the Association of Cardiologists, CV Surgeons, and Angiologists of Sfax (2025).
  • Symposium focused on personalized medicine, specifically addressing Rivaroxaban’s indications and target populations.
  • Reinforcement of Philadelphia Pharma’s commitment to supporting healthcare practitioners with innovative and targeted solutions.
  • Engaging exchanges and debates with active participation from cardiologists and moderators.
494688758_713966657832433_4914380992660808171_n
499252362_713966614499104_8610530349093215948_n
490524849_713966334499132_6830751704038860230_n
498946027_713966231165809_4406010350485878403_n (1)
493950766_713965867832512_2070161225915940073_n
494238586_713965144499251_7310855047818535221_n

Congratulations to Dr. Tarek Ellouze, Associate Professor of Cardiology at the Hédi Chaker University Hospital in Sfax, for the clarity and relevance of his presentations on complex cases: atrial fibrillation in frail elderly patients, stage 4-5 chronic kidney failure, intra-LV thrombus, TAVI bioprosthesis thrombosis, etc. Thanks also to the moderators and cardiologists present for their commitment and the quality of the discussions. Philadelphia Pharma remains true to its mission:

to support practitioners with innovative and targeted solutions, serving Tunisian patients.

A Look Back in Pictures at a Symposium of Excellence
International Event – Neurology 2025
  • Date
    July 4, 2024
  • Client
    Samira & Rufus
  • Category
  • Share